ABPO · Abpro Holdings, Inc.
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| — | — | $183K | $122K | — | |
| $373K | $989K | $2.98M | $4.27M | — | |
| $4.97M | $7.46M | $7.12M | $7.6M | — | |
| $12K | $21K | $74K | $279K | — | |
| $1.18M | $8.45M | $10.1M | $11.87M | — | |
| -$5.34M | -$8.45M | -$9.92M | -$11.75M | -$2.05M | |
| — | — | -5421.31% | -9627.87% | — | |
| -$5.33M | -$8.43M | -$9.85M | -$11.47M | — | |
| — | $1.13M | $387K | $23K | — | |
| $70K | $33K | $9000 | $63K | — | |
| $7.35M | $5.56M | $2.69M | $40K | $3.76M | |
| — | — | -$7.23M | -$11.71M | $1.71M | |
| $141.78K | — | — | $1.18M | $823.99K | |
| $2.01M | -$2.89M | -$7.23M | $2.82M | $886.92K | |
| — | — | -3951.91% | 2312.67% | — | |
| USD/shares | $2.16 | -$1.30 | -$22.31 | -$18.30 | — |
| USD/shares | $2.16 | -$1.30 | -$22.31 | -$18.30 | — |
| shares | — | 2.23M | 780.33K | 637.78K | — |
| shares | — | 2.23M | 780.33K | 637.78K | — |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2023: $276.47M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 93 similar-size Biotechnology companies (of 514 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2024 | FY2023 |
|---|---|---|
| Research and Development Services | $183,000 | — |
| Collaboration Revenue | — | $99,000 |
| Royalty | — | $23,000 |